Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer

Journal of Experimental & Clinical Cancer Research(2024)10.1186/s13046-024-03086-9Source: DataRank Database

BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer is a research paper published in Journal of Experimental & Clinical Cancer Research (2024). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

Linked data & code

geo uniprot doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 4.31)OA: goldTopics (35)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Shivani Thoidingjam ORCID,Wei‐Min Chen ORCID,Oudai Hassan,Farzan Siddiqui ORCID,Stephen L. Brown ORCID

Live enrichment

PubMed:38863037 PMC:PMC11167950 OpenAlex:https://openalex.org/W4399535698

National Cancer Institute

Grant: 1R21CA252010-01A1

Henry Ford Health System

Grant: HFHS Research Administration Start up

Henry Ford Health System

Grant: HFHS Proposal Development Award

Henry Ford Health System

Grant: HFHS-Rad Onc Start Up

Henry Ford Health System

Grant: Game on Cancer Award

Henry Ford Health System

Grant: HFCI Translational Oncology Postdoctoral Fellowship

NCI NIH HHS

Grant: R21 CA252010

FWCI

4.31

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1186/s13046-024-03086-9

publisherhttps://doi.org/10.1186/s13046-024-03086-9

publisherhttps://link.springer.com/content/pdf/10.1186/s13046-024-03086-9.pdf

publisherhttps://link.springer.com/article/10.1186/s13046-024-03086-9/fulltext.html

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38863037

Fields of Study

Microtubule and mitosis dynamicsMitochondrial Function and PathologyNuclear Structure and Function

MeSH Terms

AnimalsFemaleHumansRadiation ToleranceGene Expression Regulation, NeoplasticMice, SCIDProtein Serine-Threonine KinasesXenograft Model Antitumor AssaysCell Line, TumorCell ProliferationMiceDNA End-Joining RepairTriple Negative Breast Neoplasms

Keywords

RadioresistanceTriple-negative breast cancerCancer researchBreast cancerBUB1MedicineHomologous chromosomeCancerBiologyOncologyInternal medicineGeneticsRadiation therapyGeneDNAPKDna Damage ResponseNhejTnbcRadiation Sensitization

Sustainable Development Goals

SDG 0: Good health and well-being